Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 481–504 of 668 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of Illinois Chicago Clear all

Conditions: Diabetes Mellitus Type 1, Insomnia
Interventions: Sleep quality improvement therapy, Healthy Living; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heart Failure
Interventions: Digoxin Dosing per Nomogram, Digoxin; Other · Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 22 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Child Development Disorder, Development Delay
Interventions: Young Children's Participation and Environment Measure (YC-PEM) electronic patient-reported outcome (e-PRO); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 3 Months to 36 Months
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Age-Related Macular Degeneration, Choroidal Neovascularization
Interventions: IBI-20089/Lucentis; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 55 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV Infections
Interventions: Medical male circumcision using standard surgical technique.; Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 15 Years to 70 Years
Enrollment: 239 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV Infections
Interventions: Corrections case management; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 784 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Chicago, Illinois

Conditions: Obesity, Critical Illness
Interventions: Imipenem/Cilastatin/Relebactam 1.25g; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obesity, Diabetes, Cardiovascular Diseases
Interventions: Exercise training; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 50 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: Group A - Patient Education, Group B - Patient Education with Nutrition Counseling; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Nontuberculous Mycobacterial Disease, Atypical Mycobacterium Infections
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hot Flushes, Hot Flashes
Interventions: Bupivicaine, Saline; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 70 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Albuminuria
Interventions: Empagliflozin (oral); Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prostate Cancer
Interventions: lycopene; Dietary Supplement
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 45 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2005
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Disabilities Multiple
Interventions: ENGAGE; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Disorder Related to Renal Transplantation
Interventions: Tacrolimus XR (Envarsus); Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 60 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dementia, Cognitive Impairment, Cognitive Decline, Alzheimer Disease
Interventions: MyCog; Diagnostic Test
Lead sponsor: Northwestern University; Other
Eligibility: 45 Years and older
Enrollment: 57,589 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Persistent Corneal Epithelial Defect, Corneal Epithelial Disorders
Interventions: Allogeneic Bone-Marrow Derived Mesenchymal Stromal Cells Secretome, Vehicle Control; Drug · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Retinal Degenerations
Interventions: 2% dorzolamide; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Lung Cancer, Stage IIIb or IV
Interventions: CHESS website for lung cancer patient + internet access if needed; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 284 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 4
States / cities: Hartford, Connecticut • Chicago, Illinois • Houston, Texas + 1 more

Conditions: Muscle Weakness
Interventions: Healthy Moves for Aging Well (Healthy Moves), Active Mind for Aging Well (Active Mind); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 60 Years to 110 Years
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prediabetes
Interventions: No-carrageenan diet, Regular Diet; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Anxiety, Depression, Burnout, Professional, Emotion Regulation
Interventions: Action In Mindfulness (AIM)+, Resource+; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Sclerosis
Interventions: Guidelines for Exercise in Multiple Sclerosis (GEMS), FLEX Stretching and Toning Program; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Lower Limb Amputation Above Knee, Below Knee Amputation
Interventions: Blood pressure cuff, Neuromuscular Electrical Stimulation; Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

CBTi for the Treatment of Insomnia in Type 1 Diabetes

Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care

Implementation of Electronic Shared Decision-Making Support for Early Intervention

20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)

Papuan Indigenous Model of Male Circumcision

Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois

Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients

Role of Adiposomes in Endothelial Dysfunction

Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern

Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease

Stellate Ganglion Block (SGB) For Women for Breast Cancer

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Lycopene In Preventing of Prostate Cancer

Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological AE and Improve QOL

Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration

Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

Promoting Seniors' Health With Home Care Aides

Impact of No-carrageenan Diet on Glucose Tolerance in Prediabetes

Feasibility Testing a Meditation App for Professionals Working With Youth in the Legal System

Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.

Determining the Effects of Ischemic Conditioning and Neuromuscular Electrical Stimulation on Overall Function After Lower Limb Amputation